@article{12e2d72e1ca643e096b5b36b5be4d297,
title = "Intrahepatic myeloid-cell aggregates enable local proliferation of CD8 + T cells and successful immunotherapy against chronic viral liver infection",
abstract = "Chronic infection is difficult to overcome because of exhaustion or depletion of cytotoxic effector CD8+ T cells (cytotoxic T lymphoytes (CTLs)). Here we report that signaling via Toll-like receptors (TLRs) induced intrahepatic aggregates of myeloid cells that enabled the population expansion of CTLs (iMATEs: 'intrahepatic myeloid-cell aggregates for T cell population expansion') without causing immunopathology. In the liver, CTL proliferation was restricted to iMATEs that were composed of inflammatory monocyte-derived CD11b+ cells. Signaling via tumor-necrosis factor (TNF) caused iMATE formation that facilitated costimulation dependent on the receptor OX40 for expansion of the CTL population. The iMATEs arose during acute viral infection but were absent during chronic viral infection, yet they were still induced by TLR signaling. Such hepatic expansion of the CTL population controlled chronic viral infection of the liver after vaccination with DNA. Thus, iMATEs are dynamic structures that overcome regulatory cues that limit the population expansion of CTLs during chronic infection and can be used in new therapeutic vaccination strategies.",
author = "Huang, {Li Rung} and Dirk Wohlleber and Florian Reisinger and Jenne, {Craig N.} and Cheng, {Ru Lin} and Zeinab Abdullah and Schildberg, {Frank A.} and Margarete Odenthal and Dienes, {Hans Peter} and {Van Rooijen}, Nico and Edgar Schmitt and Natalio Garbi and Michael Croft and Christian Kurts and Paul Kubes and Ulrike Protzer and Mathias Heikenwalder and Knolle, {Percy A.}",
note = "Funding Information: We thank D. Kull, R. Hillermann, O. Seelbach, N. Simonavicius, M. Wolf and the flow cytometry core facility of the Institutes of Molecular Medicine and Experimental Immunology, University of Bonn for technical support. Supported by the Helmholtz Association (M.H.), the Hofschneider Foundation (M.H.), the European Research Council (LiverCancerMech; M.H.), the Helmholtz Alliance Preclinical Comprehensive Cancer Center (M.H.), Sonderforschungsbereich (36 to M.H., and 704, TR57 and 670 to P.K.), the Helmholtz Alliance on Immunotherapy of Cancer (P.K.), the Bundesministerium f{\"u}r Bildung und Forschung projects Virtual Liver and PeTra (P.K.) and the Excellence Cluster ImmunoSensation (P.K.).",
year = "2013",
month = jun,
doi = "10.1038/ni.2573",
language = "English",
volume = "14",
pages = "574--583",
journal = "Nature Immunology",
issn = "1529-2908",
publisher = "Nature Publishing Group",
number = "6",
}